GLP-1 Drugs Whitepaper: Understanding the Complexities of Coverage for Diabetes and Obesity
Posted on December 11, 2023
GLP-1 drugs have emerged as a highly effective treatment for type 2 diabetes and, more recently, weight loss. Due to their success in weight loss outcomes, these drugs have become a hot topic of discussion among pharmacy benefits experts. As the GLP-1 landscape evolves, payers must make ongoing decisions for GLP-1 coverage.
To help inform your benefits strategy, we have released a white paper that aims to assist plans in comprehending the subtle nuances and implications surrounding GLP-1s. Download your copy today and stay ahead of the curve!
This paper covers:
- GLP-1 Drugs: A Treatment for Both Type 2 Diabetes and Obesity
- Market Demand for GLP-1 Drugs for Weight Loss
- Considerations for GLP-1 Coverage Decisions
- Strategies for GLP-1 Coverage for Weight Loss
- And more!
